Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03967340

PREdiction of Chronic LUng Allograft Dysfunction

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

Chronic lung allograft dysfunction (CLAD) is the leading cause of long-term mortality after lung transplantation. Several risk factors for CLAD have been identified, but the exact pathophysiology and triggering molecular factors remain largely unknown. Moreover, in clinical practice, no integration of the different risk factors is achieved. CLAD is therefore diagnosed most often late with the persistent decline in respiratory function, revealing a profound and irreversible alteration of the pulmonary graft. Several blood biomarkers that can predict the occurrence of CLAD more than 6 months before clinical diagnosis have been identified and validated. From these preliminary results, a composite score is being developed from independent samples from the COLT (COhort in Lung Transplantation) cohort. The main objective of this project is to validate this robust and predictive composite score (biological and clinical) of CLAD.

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

OBSERVATIONAL

Enrollment

240

Start Date

2020-09-10

Completion Date

2027-03

Last Updated

2025-05-16

Healthy Volunteers

No

Locations (10)

CHU de Bordeaux

Bordeaux, France

CHU de Grenoble

Grenoble, France

Centre Chirurgical Marie Lannelongue

Le Plessis-Robinson, France

CHU de Lyon

Lyon, France

AP-HM

Marseille, France

CHU de Nantes

Nantes, France

Hôpital Bichat

Paris, France

CHRU de Strasbourg

Strasbourg, France

Hôpital Foch

Suresnes, France

CHU de Toulouse

Toulouse, France